CA-ARMIS
16.4.2024 13:01:29 CEST | Business Wire | Press release
Armis, the asset intelligence cybersecurity company, is warning that global elections will be the largest attack vector for nation-state actors looking to cause mass disruption in 2024.
Data from Armis’ second annual global cyberwarfare report, The Invisible Front Line: AI-Powered Cyber Threats Illuminate the Dark Side, show organizations and governments worldwide face critical threat levels from sophisticated nation-states and admittedly are severely underprepared to defend against impending cyberwarfare attacks.
“In the biggest global election year in history, democracy is the primary target of nation-state threat actors,” said Nadir Izrael, CTO and Co-Founder, Armis. “Make no mistake - we are in a cyber arms race against our adversaries and society as we know it is at risk. It’s essential that we immediately shift from a reactive to a proactive, defensive stance before it’s too late.”
Thirty-nine percent of IT leaders worldwide believe cyberwarfare could affect the integrity of an electoral process and 42% believe cyberwarfare could target the media. As half of the global population across 76 nations prepare to head to the polls this year, this pre-existing doubt in the sanctity of the electoral process has laid the groundwork for calculated assaults on public trust. When successful, cyberwarfare attacks could destabilize economies and cripple entire commercial and societal systems.
Additionally, 60% of IT leaders say digital transformation projects have stalled or stopped entirely due to cyberwarfare risks. However, innovation has not stalled for bad actors who continue to push the boundaries. Elite researchers from Armis Labs have uncovered the tactics of nation-state actors affiliated with Russia, North Korea, Iran and China that are using AI for advanced cyber capabilities. Armis Labs is also seeing an increase in the combination of weaponized vulnerabilities being used by threat actors in a single attack.
“Relying on legacy technologies and manual security processes is the equivalent of bringing a knife to a gunfight, given the threats we’re up against and the arsenal of nation-state actors,” continued Izrael. “It is critical that security leaders fight fire with fire, leveraging AI-powered solutions that empower them with actionable intelligence before a vulnerability is announced, before an attack is launched and before their organization is impacted. Forewarned is forearmed.”
Armis Centrix™ for Actionable Threat Intelligence is an early warning, AI-based system that leverages dark web, dynamic honeypots and human intelligence (HUMINT) to anticipate threats, understand their potential impact and take preemptive action to neutralize them, effectively moving the security posture from defense to offense.
The 2024 Armis Cyberwarfare Report, The Invisible Front Line: AI-Powered Cyber Threats Illuminate the Dark Side, is based on a study of over 2,600 global IT decision-makers and proprietary data from Armis Labs.
Read the full report from Armis, including a comprehensive breakdown of the findings for each region of respondents, here.
About Armis
Armis, the asset intelligence cybersecurity company, protects the entire attack surface and manages the organization's cyber risk exposure in real time. In a rapidly evolving, perimeter-less world Armis ensures that organizations continuously see, protect and manage all critical assets. Armis secures Fortune 100, 200 and 500 companies as well as national governments, state and local entities to help keep critical infrastructure, economies and society stay safe and secure 24/7. Armis is a privately held company headquartered in California.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240416828074/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Incyte Announces Positive CHMP Opinion for Zynyz® (retifanlimab) for First-Line Treatment of Advanced Squamous Cell Carcinoma of the Anal Canal (SCAC)30.1.2026 15:29:00 CET | Press release
Pending the European Commission decision, Zynyz® (retifanlimab) in combination with carboplatin and paclitaxel (platinum-based chemotherapy) will be the first PD-1 immunotherapy treatment for patients with advanced squamous cell carcinoma of the anal canal (SCAC) in EuropeGlobally, the prevalence of SCAC is estimated at around 1 or 2 cases per 100,000 people, with a higher incidence in women than in men1,2,3The Committee for Medicinal Products for Human Use (CHMP) positive opinion is based on data from the Phase 3 POD1UM-303/InterAACT2 trial which showed patients with advanced SCAC achieved significantly improved progression-free survival with Zynyz in combination with carboplatin and paclitaxel as a first-line treatment4 Incyte (Nasdaq:INCY) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion recommending the approval of Zynyz® (retifanlimab) in combination with carboplatin and paclitaxel (
Mediawan to Acquire The North Road Company, Creating a New Global Independent Content Platform30.1.2026 13:32:00 CET | Press release
Mediawan, the leading independent European studio led by Pierre-Antoine Capton, co-founded by Capton, Xavier Niel and Matthieu Pigasse, today announced the signing of an agreement to acquire The North Road Company (“North Road”), the preeminent independent U.S.-based studio founded by Peter Chernin. The combination creates one of the world’s largest independent studios with major creative hubs in the five continents and capabilities spanning all genres, formats and audiences. Together, Mediawan and North Road will have a stronger ability to accelerate the development of powerful IP, foster fresh creative synergies through format adaptations and co-production opportunities, and deliver ever greater value to viewers, talent and partners worldwide. The acquisition brings together two of the most dynamic independent studios in the sector with world-class creative talent, premium IP, and the scale to deliver content at the highest level. In an industry undergoing significant consolidation,
BrightSign Powers Intelligent Signage Experiences at ISE 202630.1.2026 09:00:00 CET | Press release
The Latest Players and AI Capabilities Drive Captivating, Personalized, and Interactive Signage With more industries embracing the power of visual storytelling, BrightSign, the provider of the most advanced, capable, and trusted digital media players and operating system, will showcase the latest developments in digital signage technology at ISE 2026 in Barcelona, Spain from February 3-6, 2026. BrightSign’s latest innovations come to life at booth #4S-150 through interactive real-world demos featuring retail, QSR, transportation, and corporate use cases. Visitors can test new AI-powered object detection capabilities of BrightSign players, allowing them to pick up an object and see the content on the screen respond immediately. Booth activations will be powered by BrightSign’s reliable platform including bsn.Control, BrightSignOS™, brightAuthor connected, and its global partner ecosystem. “In today’s immersive, personalized and visual world, the stakes have never been higher for powerfu
Candela Ushers in a New Era of Aesthetic Innovation at IMCAS Paris With the Launch of the Glacē™ System30.1.2026 08:30:00 CET | Press release
Iconic Vbeam® Pro and Matrix™ Systems showcased ahead of broader commercial availability Candela, a global leader in energy-based aesthetic technologies, today announced the European launch of the Glacē™ System, a facial treatment platform that signals a bold new chapter for the company and the future of aesthetic medicine. In addition to the launch of the Glacē System, Candela will also showcase its Matrix system for radiofrequency-based skin renewal and its iconic Vbeam® Pro vascular treatment platform at IMCAS 2026. Both Matrix and VBeam Pro platforms are currently available in select EMEA markets and are expected to be comprehensively launched shortly, further strengthening Candela’s leadership in the energy-based device market. Unveiled at the IMCAS World Congress 2026, these launches underscore Candela’s continued commitment to delivering innovative, science-backed treatment solutions for high-demand patient needs. Candela leads the industry in clinical efficacy and safety, suppo
Merz Therapeutics Appoints Dan Staner as President, Region Europe30.1.2026 08:00:00 CET | Press release
Merz Therapeutics today announced the appointment of Dan Staner as President, Region Europe, effective February 1, 2026. In this role, Dan will oversee the company’s European business and drive regional growth. Dan will report directly to Merz Therapeutics Chief Executive Officer, Stefan König, and will join the Therapeutics Executive Team. His appointment reflects the company’s continued commitment to strengthening its leadership capabilities and accelerating its growth strategy across key European markets. “Dan brings a strong track record of building and scaling biopharmaceutical businesses across Europe,” said Stefan König, CEO of Merz Therapeutics. “His deep commercial, strategic, and regional leadership experience will be instrumental in advancing our growth ambitions, expanding patient access to our therapies, and further strengthening our presence in Europe. We are very pleased to welcome Dan to Merz Therapeutics.” Throughout his career, Dan has held senior leadership roles i
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
